(Q35583059)

9 August 2017

1 reference

title

Review article: oral ulceration--aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic (English)

1 reference

9 August 2017

Oral ulceration – aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

1 April 2024

1 reference

E. A. Field

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616160

1 April 2024

R. B. Allan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616160

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616160

full work available at URL

1 April 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01782.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616160

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01782.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01782.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Alimentary Pharmacology & Therapeutics

1 April 2024

published in

1 reference

9 August 2017

18

1 reference

9 August 2017

10

1 reference

9 August 2017

949-962

1 reference

Adverse drug reactions in the mouth

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Celiac disease and recurrent aphthous stomatitis: a report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

The diagnosis and management of recurrent aphthous stomatitis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Prognosis and clinical relevance of recurrent oral ulceration in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Vasculitis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Treatment of Behçet's disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Behçet's disease: a new target for anti-tumour necrosis factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Nicorandil can induce severe oral ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Recurrent aphthous stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Can you catch Behçet's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Drug-induced aphthous ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Giant oral aphthous ulcers induced by nicorandil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Severe stomatitis caused by penicillamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

[Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01782.X

Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Close association of HLA-B51 in persons with recurrent aphthous stomatitis

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Psychologic stress and recurrent aphthous ulceration

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Progeston therapy for menstrually related aphthae

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

An epidemiological study of factors associated with recurrent aphthae in women

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Coeliac disease associated with recurrent aphthae

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Recurrent aphthous stomatitis

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

High prevalence of DRW10 and DQW1 antigens in celiac disease associated with recurrent aphthous stomatitis

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Gluten-sensitive recurrent aphthous stomatitis

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Effects of dietary gluten elimination in patients with recurrent minor aphthous stomatitis and no detectable gluten enteropathy

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Serum vitamin B12, folate, and iron levels in recurrent aphthous ulceration

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Major aphthous ulcers in patients with HIV disease

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Recurrent aphthous ulcers in association with HIV infection. Description of ulcer types and analysis of T-lymphocyte subsets

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Esophageal ulcers in immunodeficiency with elevated levels of IgM and neutropenia

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Syndrome of periodic fever, pharyngitis, and aphthous stomatitis

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

A case of Sweet's syndrome (acute febrile neutrophilic dermatosis) with palatal ulceration

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Prevention of recurrent aphthous stomatitis with colchicine: an open trial

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Clinical differentiation of oral ulceration in Behçet's disease.

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Immunopathogenesis of Behçet's disease

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Practical Treatment Recommendations for Pharmacotherapy of Behcetʼs Syndrome

1 April 2024

52

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Potential new therapeutic options in Behçet's syndrome

1 April 2024

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Behçet's disease: immunopathologic and therapeutic aspects

1 April 2024

54

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Novel approaches to Behçet's disease

1 April 2024

55

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

1 April 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Colchicine in the treatment of the cutaneous manifestations of Behçet's disease

1 April 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Pyostomatitis vegetans: report of three cases and review of the literature

1 April 2024

68

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Pyostomatitis vegetans and associated systemic disease

1 April 2024

70

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Oral manifestations of Crohn's disease

1 April 2024

72

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Aspirin burn of the oral cavity

1 April 2024

74

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Pouching of medications in the mouth: a case report

1 April 2024

76

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs

1 April 2024

78

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Nicorandil-induced severe oral ulceration: a newly recognized drug reaction

1 April 2024

79

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

Oral complications of cancer therapies: prevention and management

1 April 2024

84

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01782.X

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference